title: Acetyl-L-carnitine for symptomatic diabetic neuropathy.
authors.forename: A
authors.initials: A
authors.lastname: Quatraro
authors.forename: P
authors.initials: P
authors.lastname: Roca
authors.forename: C
authors.initials: C
authors.lastname: Donzella
authors.forename: R
authors.initials: R
authors.lastname: Acampora
authors.forename: R
authors.initials: R
authors.lastname: Marfella
authors.forename: D
authors.initials: D
authors.lastname: Giugliano
mesh_terms: D000108:Acetylcarnitine / Q000627:therapeutic use*; D018592:Cross-Over Studies; D003922:Diabetes Mellitus, Type 1 / Q000150:complications / Q000188:drug therapy; D003929:Diabetic Neuropathies / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007328:Insulin / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D010147:Pain Measurement; D012720:Severity of Illness Index; D016037:Single-Blind Method
chemical_list: D007328:Insulin; D000108:Acetylcarnitine